VanEck Pharmaceutical ETF (PPH) — ()
Key Metrics
News
Why PPH Keeps Working When Single Themes Break
Published: by:
Sentiment: Positive ()
The VanEck Pharmaceutical ETF offers concentrated exposure to large-cap global pharma leaders, balancing growth, defensive, and non-drug cash flow stabilizers. PPH has demonstrated resilience, outperforming during market drawdowns and delivering …
Read More
3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List
Published: by:
Sentiment: Positive ()
The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in the …
Read More
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
Published: by:
Sentiment: Negative ()
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on …
Read More
Pharma stocks gain, as Trump's tariff move actually could be a win for the sector
Published: by:
Sentiment: Positive ()
Pharmaceutical stocks mostly gained Friday, as traders appeared to shrug off or even cheer President Donald Trump's rollout of a new tariff plan for drugmakers.
Read More
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
Published: by:
Sentiment: Negative ()
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Read More
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Published: by:
Sentiment: Neutral ()
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the …
Read More
ETFs on the Move Post U.S.-China Trade Deal
Published: by:
Sentiment: Positive ()
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Read More
A Look at Pharma ETFs After Strong Q1 Earnings
Published: by:
Sentiment: Positive ()
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Read More
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger
Published: by:
Sentiment: Neutral ()
VanEck Pharmaceutical ETF holds a mixed outlook due to high fees and tariff risks, warranting a hold rating despite strong top holdings. PPH's top holdings like Eli Lilly and Johnson …
Read More